Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Kamp, Timothy J  [Clear All Filters]
2024
Gregorich ZR, Zhang Y, Kamp TJ, Granzier H, Guo W. Mechanisms of RBM20 Cardiomyopathy: Insights From Model Systems. Circ Genom Precis Med. 2024:e004355.
2023
Cheng Y-C, Hsieh ML, Lin C-J, Chang CMC, Huang C-Y, Puntney R, Moy AWu, Ting C-Y, Chan DZhing Herr, Nicholson MW, et al. Combined Treatment of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Endothelial Cells Regenerate the Infarcted Heart in Mice and Non-Human Primates. Circulation. 2023.
Chen T-A, Sharma D, Jia W, Ha D, Man K, Zhang J, Yang Y, Zhou Y, Kamp TJ, Zhao F. Detergent-Based Decellularization for Anisotropic Cardiac-Specific Extracellular Matrix Scaffold Generation. Biomimetics (Basel). 2023;8(7).
Rossler KJ, de Lange WJ, Mann MW, Aballo TJ, Melby JA, Zhang J, Kim G, Bayne EF, Zhu Y, Farrell ET, et al. Lactate and Immunomagnetic-purified hiPSC-derived cardiomyocytes generate comparable engineered cardiac tissue constructs. JCI Insight. 2023.
Salamon RJ, McKeon MC, Bae J, Zhang X, Paltzer WG, Wanless KN, Schuett AR, Nuttall DJ, Nemr SA, Sridharan R, et al. LRRC10 regulates mammalian cardiomyocyte cell cycle during heart regeneration. NPJ Regen Med. 2023;8(1):39.
Turner DGP, de Lange WJ, Zhu Y, Coe CL, Simcox J, Ge Y, Kamp TJ, J Ralphe C, Glukhov AV. Neutral sphingomyelinase regulates mechanotransduction in human engineered cardiac tissues and mouse hearts. J Physiol. 2023.
2022
Huang CYing, Nicholson MW, Wang JYuan, Ting CYu, Tsai MHeng, Cheng YChe, Liu CLin, Chan DZH, Lee YChan, Hsu CChuan, et al. Population-based high-throughput toxicity screen of human iPSC-derived cardiomyocytes and neurons. Cell Rep. 2022;39(1):110643.
2021
Floy ME, Givens SE, Matthys OB, Mateyka TD, Kerr CM, Steinberg AB, Silva AC, Zhang J, Mei Y, Ogle BM, et al. Developmental lineage of human pluripotent stem cell-derived cardiac fibroblasts affects their functional phenotype. FASEB J. 2021;35(9):e21799.
Melby JA, de Lange WJ, Zhang J, Roberts DS, Mitchell SD, Tucholski T, Kim G, Kyrvasilis A, McIlwain SJ, Kamp TJ, et al. Functionally Integrated Top-Down Proteomics for Standardized Assessment of Human Induced Pluripotent Stem Cell-Derived Engineered Cardiac Tissues. J Proteome Res. 2021.
Anderson CL, Langer ER, Routes TC, McWilliams SF, Bereslavskyy I, Kamp TJ, Eckhardt LL. Most myopathic lamin variants aggregate: a functional genomics approach for assessing variants of uncertain significance. NPJ Genom Med. 2021;6(1):103.
2019
Alexanian RA, Mahapatra K, Lang D, Vaidyanathan R, Markandeya YS, Gill RK, Zhai AJ, Dhillon A, Lea MR, Abozeid S, et al. Induced cardiac progenitor cells repopulate decellularized mouse heart scaffolds and differentiate to generate cardiac tissue. Biochim Biophys Acta Mol Cell Res. 2019:118559.
2016
Biermann M, Kamp TJ. Cardiotoxicity in a dish: new insights for personalized therapy. Nat Med. 2016;22(5):459-460.
Nelson DO, Lalit PA, Biermann M, Markandeya YS, Capes DL, Addesso L, Patel G, Han T, John MC, Powers PA, et al. Irx4 Marks a Multipotent, Ventricular-Specific Progenitor Cell. Stem Cells. 2016.
2014
Raval KK, Kamp TJ. Cardiomyopathy, mitochondria and Barth syndrome: iPSCs reveal a connection. Nat Med. 2014;20(6):585-586.
Lalit PA, Hei DJ, Raval AN, Kamp TJ. Induced pluripotent stem cells for post-myocardial infarction repair: remarkable opportunities and challenges. Circ Res. 2014;114(8):1328-45.